These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3990417)

  • 1. [Glycosylated hemoglobin: evaluation of labile and stable fractions in type I and type II diabetes].
    Rosel P; Barragán F; Martínez M; Vinzia C; Marigo M; Navarro MA
    Med Clin (Barc); 1985 Mar; 84(9):349-52. PubMed ID: 3990417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycosylated hemoglobin and the evaluation of control in ambulatory diabetic patients].
    Roy L; Havrankova J; Bannon P; Matte R; Bélanger R; D'Amour P
    Union Med Can; 1983 Sep; 112(9):806-9. PubMed ID: 6649182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of glycosylated hemoglobin (HbA1) and fasting blood glucose in normal subjects and in patients with diabetes mellitus].
    Matsubara LS; Anselmo MA; de Paiva SA; Lima LC; Machado PE; Curi PR
    AMB Rev Assoc Med Bras; 1985; 31(11-12):227-31. PubMed ID: 3879703
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of the determination of glycosylated proteins and glycosylated hemoglobin in therapy control of diabetic patients].
    Hay U; Schernthaner G
    Z Med Lab Diagn; 1989; 30(1):67-9. PubMed ID: 2718583
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic value of glycosylated protein in diabetes mellitus].
    Andreeva AP; Levina AA; Arapova SD; Dmitrieva MG; Mazovetskiĭ AG
    Sov Med; 1987; (2):22-5. PubMed ID: 3576312
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of glycosylated hemoglobin levels (HbA1c) (II). Studies in patients with carbohydrate intolerance and clinico-biological correlations in diabetic patients].
    Fernández Fernández I; Hernández C; González MC; Roldán E; Durán García S
    Med Clin (Barc); 1983 Dec; 81(19):839-43. PubMed ID: 6656459
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems in the interpretation of the percentage of glycosylated hemoglobin in patients with diabetes mellitus].
    Tack CJ; Lutterman JA
    Ned Tijdschr Geneeskd; 1995 Nov; 139(45):2289-92. PubMed ID: 7501057
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study on the levels of glycosylated hemoglobin and fasting plasma glucose in diabetics].
    Xiang KS
    Zhonghua Yi Xue Za Zhi; 1985 Aug; 65(8):449-53. PubMed ID: 3931870
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fructosamine and glycosylated hemoglobin as parameters of hyperglycemia].
    Llopis R; Cubillo P
    Rev Clin Esp; 1989 Apr; 184(6):303-4. PubMed ID: 2756218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamic changes in the blood glucose, glycosylated hemoglobin and glycosylated serum protein values in patients with diabetes mellitus].
    Kalpazanova N; Dosheva I; Klechkova L
    Vutr Boles; 1987; 26(6):107-10. PubMed ID: 3439144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should haemoglobin A1C be used for diagnosis of diabetes mellitus in Malawi?
    Nakanga WP; Crampin A; Nyirenda M
    Malawi Med J; 2016 Mar; 28(1):28-30. PubMed ID: 27217915
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycosylated hemoglobin in a population-based study of diabetes.
    Klein R; Klein BE; Moss SE; Shrago ES; Spennetta TL
    Am J Epidemiol; 1987 Sep; 126(3):415-28. PubMed ID: 3303917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience and methodology of glycosylated hemoglobin determination].
    Korolev VA
    Lik Sprava; 2010; (1-2):57-69. PubMed ID: 20608028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of the determination of glycosylated hemoglobins in diabetes mellitus].
    Grinshpun MN; Mazovetskiĭ AG; Galenok VA; Dikker VE
    Probl Endokrinol (Mosk); 1983; 29(6):80-5. PubMed ID: 6419224
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of past glycemic control. Measure fructosamine, hemoglobin A1, or both?
    Dominiczak MH; Smith LA; McNaught J; Paterson KR
    Diabetes Care; 1988 Apr; 11(4):359-60. PubMed ID: 3402293
    [No Abstract]   [Full Text] [Related]  

  • 16. Aiming for the best control of glycemia in patients with heart failure and type 2 diabetes the "sweet spot".
    Weinrauch LA; Lewis EF
    J Am Coll Cardiol; 2009 Jul; 54(5):429-31. PubMed ID: 19628118
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical relevance of fetal hemoglobin in IDDM and NIDDM patients.
    Kopp HP; Krugluger W; Festa A; Schernthaner G
    Diabetes Care; 1995 Jun; 18(6):883-4. PubMed ID: 7555521
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glycosylated hemoglobin compared with blood glucose and lipid parameters in diabetics treated with an insulin preparation and diet].
    Preradov-Mikić M
    Med Pregl; 1987; 40(3-4):105-9. PubMed ID: 3312983
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of colorimetric method for analysis of glycated hemoglobin].
    Korolev VA; Golovskaia GG; Belokurenko VP; Chimirichkina NI; Malakhova OIu; Gordeeva GI
    Klin Lab Diagn; 2001 Dec; (12):12-4. PubMed ID: 11840821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexamining metrics for glucose control.
    Rubinow KB; Hirsch IB
    JAMA; 2011 Mar; 305(11):1132-3. PubMed ID: 21406652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.